This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ethris Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Sandra Hocke
Introduction
Sandra Hocke is a prominent inventor based in Haimhausen, Germany. She has made significant strides in the field of biotechnology, particularly through her work on polyribonucleotides. Her innovative approach has the potential to impact therapeutic applications for various diseases.
Latest Patents
Sandra Hocke holds a patent for a groundbreaking invention titled "Polyribonucleotide containing deuterated nucleotides." This patent describes polyribonucleotides that include deuterated adenosine, cytidine, guanosine, and/or uridine residues. These polyribonucleotides exhibit reduced immunogenicity and enhanced expression, making them valuable for therapeutic use in treating diseases.
Career Highlights
Sandra is currently associated with Ethris GmbH, a company focused on developing RNA-based therapeutics. Her work at Ethris GmbH has positioned her as a key player in the advancement of innovative medical solutions. With her expertise, she continues to contribute to the evolving landscape of biotechnology.
Collaborations
Throughout her career, Sandra has collaborated with notable colleagues, including Carsten Rudolph and Johannes Geiger. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in her field.
Conclusion
Sandra Hocke's contributions to biotechnology, particularly through her patent on polyribonucleotides, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.